ESSA Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:EPIX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
08 Nov 24	BuyUS$6,795,040	Tang Capital Management, LLC	Company		4,300,000	US$1.83

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EPIX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	986,834	2.22%
General Public	7,427,970	16.7%
Institutions	12,749,295	28.7%
Hedge Funds	23,224,451	52.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 83% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.7%	BVF Partners L.P.	8,748,629	US$14.1m	0%	0.45%
9.69%	Tang Capital Management, LLC	4,300,000	US$6.9m	0%	0.51%
9.66%	Soleus Capital Management, L.P.	4,288,167	US$6.9m	1.84%	0.54%
9.42%	BML Capital Management, LLC	4,183,223	US$6.7m	0%	3.58%
9.42%	Morgan Stanley, Investment Banking and Brokerage Investments	4,181,148	US$6.7m	0.08%	no data
7.35%	RTW Investments, LP	3,261,496	US$5.3m	41.9%	0.08%
6.18%	PFM Health Sciences, LP	2,742,936	US$4.4m	-7.5%	0.29%
3.32%	Adage Capital Management, L.P.	1,474,165	US$2.4m	0%	no data
1.81%	Rhenman & Partners Asset Management AB	804,649	US$1.3m	-0.17%	0.09%
1.77%	Franklin Berger	784,404	US$1.3m	0%	no data
1.53%	Rock Springs Capital Management LP	677,005	US$1.1m	0%	0.04%
0.78%	Parkman Healthcare Partners LLC	345,902	US$556.9k	37.2%	0.08%
0.63%	Schonfeld Strategic Advisors LLC	278,000	US$447.6k	-12%	no data
0.59%	Medical Strategy GmbH, Asset Management Arm	261,304	US$420.7k	0%	0.03%
0.17%	Canadian Imperial Bank of Commerce, Asset Management Arm	73,587	US$118.5k	-8.31%	no data
0.15%	David Parkinson	65,765	US$105.9k	0%	no data
0.14%	D. E. Shaw & Co., L.P.	62,955	US$101.4k	-0.83%	no data
0.11%	American Century Investment Management Inc	46,652	US$75.1k	-0.21%	no data
0.1%	BNP Paribas Arbitrage Sa, Asset Management Arm	44,495	US$71.6k	2.06%	no data
0.097%	Richard Glickman	43,240	US$69.6k	0%	no data
0.093%	Kennedy Capital Management LLC	41,092	US$66.2k	19.2%	no data
0.09%	Royal Bank of Canada, Banking & Securities Investments	40,022	US$64.4k	12.6%	no data
0.075%	David Wood	33,343	US$53.7k	0%	no data
0.068%	Scott Requadt	30,002	US$48.3k	0%	no data
0.064%	Citadel Advisors LLC	28,479	US$45.9k	13.4%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 02:22
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ESSA Pharma Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Joseph Pantginis	H.C. Wainwright & Co.
Maurice Raycroft	Jefferies LLC
Soumit Roy	JonesTrading Institutional Services, LLC